413 related articles for article (PubMed ID: 9679816)
1. T-cell alterations in cardiac allograft recipients after B7 (CD80 and CD86) blockade.
Woodward JE; Bayer AL; Chavin KD; Blue ML; Baliga P
Transplantation; 1998 Jul; 66(1):14-20. PubMed ID: 9679816
[TBL] [Abstract][Full Text] [Related]
2. Enhanced allograft survival via simultaneous blockade of transferrin receptor and interleukin-2 receptor.
Woodward JE; Bayer AL; Baliga P
Transplantation; 1999 Nov; 68(9):1369-76. PubMed ID: 10573078
[TBL] [Abstract][Full Text] [Related]
3. Costimulatory function and expression of CD40 ligand, CD80, and CD86 in vascularized murine cardiac allograft rejection.
Hancock WW; Sayegh MH; Zheng XG; Peach R; Linsley PS; Turka LA
Proc Natl Acad Sci U S A; 1996 Nov; 93(24):13967-72. PubMed ID: 8943044
[TBL] [Abstract][Full Text] [Related]
4. Blockade of multiple costimulatory receptors induces hyporesponsiveness: inhibition of CD2 plus CD28 pathways.
Woodward JE; Qin L; Chavin KD; Lin J; Tono T; Ding Y; Linsley PS; Bromberg JS; Baliga P
Transplantation; 1996 Oct; 62(7):1011-8. PubMed ID: 8878397
[TBL] [Abstract][Full Text] [Related]
5. Increased apoptosis of immunoreactive host cells and augmented donor leukocyte chimerism, not sustained inhibition of B7 molecule expression are associated with prolonged cardiac allograft survival in mice preconditioned with immature donor dendritic cells plus anti-CD40L mAb.
Lu L; Li W; Zhong C; Qian S; Fung JJ; Thomson AW; Starzl TE
Transplantation; 1999 Sep; 68(6):747-57. PubMed ID: 10515374
[TBL] [Abstract][Full Text] [Related]
6. Costimulatory molecule-deficient dendritic cell progenitors (MHC class II+, CD80dim, CD86-) prolong cardiac allograft survival in nonimmunosuppressed recipients.
Fu F; Li Y; Qian S; Lu L; Chambers F; Starzl TE; Fung JJ; Thomson AW
Transplantation; 1996 Sep; 62(5):659-65. PubMed ID: 8830833
[TBL] [Abstract][Full Text] [Related]
7. Prevention of renal allograft rejection in primates by blocking the B7/CD28 pathway.
Ossevoort MA; Ringers J; Kuhn EM; Boon L; Lorré K; van den Hout Y; Bruijn JA; de Boer M; Jonker M; de Waele P
Transplantation; 1999 Oct; 68(7):1010-8. PubMed ID: 10532543
[TBL] [Abstract][Full Text] [Related]
8. Blockade of the CD40-CD40 ligand pathway potentiates the capacity of donor-derived dendritic cell progenitors to induce long-term cardiac allograft survival.
Lu L; Li W; Fu F; Chambers FG; Qian S; Fung JJ; Thomson AW
Transplantation; 1997 Dec; 64(12):1808-15. PubMed ID: 9422424
[TBL] [Abstract][Full Text] [Related]
9. Differential effects of transferrin receptor blockade on the cellular mechanisms involved in graft rejection.
Bayer AL; Baliga P; Woodward JE
Transpl Immunol; 1999 Sep; 7(3):131-9. PubMed ID: 10608296
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of transplant rejection following treatment with anti-B7-2 and anti-B7-1 antibodies.
Lenschow DJ; Zeng Y; Hathcock KS; Zuckerman LA; Freeman G; Thistlethwaite JR; Gray GS; Hodes RJ; Bluestone JA
Transplantation; 1995 Nov; 60(10):1171-8. PubMed ID: 7482727
[TBL] [Abstract][Full Text] [Related]
11. In vivo CD86 blockade inhibits CD4+ T cell activation, whereas CD80 blockade potentiates CD8+ T cell activation and CTL effector function.
Lang TJ; Nguyen P; Peach R; Gause WC; Via CS
J Immunol; 2002 Apr; 168(8):3786-92. PubMed ID: 11937530
[TBL] [Abstract][Full Text] [Related]
12. The role of CD80, CD86, and CTLA4 in alloimmune responses and the induction of long-term allograft survival.
Judge TA; Wu Z; Zheng XG; Sharpe AH; Sayegh MH; Turka LA
J Immunol; 1999 Feb; 162(4):1947-51. PubMed ID: 9973463
[TBL] [Abstract][Full Text] [Related]
13. Multiple negative feedbacks on CD152 expression in allograft tolerance.
Tsai MK; Ho HN; Chien HF; Tzeng MC; Chen CH; Lee PH
Transplantation; 2005 Jan; 79(2):174-81. PubMed ID: 15665765
[TBL] [Abstract][Full Text] [Related]
14. The role of B7 ligands (CD80 and CD86) in CD152-mediated allograft tolerance: a crosscheck hypothesis.
Tsai MK; Ho HN; Chien HF; Ou-Yang P; Lee CJ; Lee PH
Transplantation; 2004 Jan; 77(1):48-54. PubMed ID: 14724434
[TBL] [Abstract][Full Text] [Related]
15. Transferrin receptor in T cell activation and transplantation.
Bayer AL; Baliga P; Woodward JE
J Leukoc Biol; 1998 Jul; 64(1):19-24. PubMed ID: 9665270
[TBL] [Abstract][Full Text] [Related]
16. Coadministration of either cyclosporine or steroids with humanized monoclonal antibodies against CD80 and CD86 successfully prolong allograft survival after life supporting renal transplantation in cynomolgus monkeys.
Hausen B; Klupp J; Christians U; Higgins JP; Baumgartner RE; Hook LE; Friedrich S; Celnicker A; Morris RE
Transplantation; 2001 Sep; 72(6):1128-37. PubMed ID: 11579312
[TBL] [Abstract][Full Text] [Related]
17. Costimulatory signal through CD86 is important in Th2 response in Trichinella spiralis infected mice.
Wang Z; Takamoto M; Sugane K
Parasite Immunol; 2000 Mar; 22(3):121-30. PubMed ID: 10672193
[TBL] [Abstract][Full Text] [Related]
18. Induction therapy with monoclonal antibodies specific for CD80 and CD86 delays the onset of acute renal allograft rejection in non-human primates.
Kirk AD; Tadaki DK; Celniker A; Batty DS; Berning JD; Colonna JO; Cruzata F; Elster EA; Gray GS; Kampen RL; Patterson NB; Szklut P; Swanson J; Xu H; Harlan DM
Transplantation; 2001 Aug; 72(3):377-84. PubMed ID: 11502964
[TBL] [Abstract][Full Text] [Related]
19. A crucial role of host CD80 and CD86 in rat cardiac xenograft rejection in mice.
Kano M; Bashuda H; Yagita H; Okumura K; Morishita Y
Transplantation; 1998 Mar; 65(6):837-43. PubMed ID: 9539097
[TBL] [Abstract][Full Text] [Related]
20. Administration of dendritic cells transduced with antisense oligodeoxyribonucleotides targeting CD80 or CD86 prolongs allograft survival.
Liang X; Lu L; Chen Z; Vickers T; Zhang H; Fung JJ; Qian S
Transplantation; 2003 Aug; 76(4):721-9. PubMed ID: 12973117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
